Biotech News
Certara Reports Third Quarter 2025 Financial Results
ir.certara.com2026-05-06 14:46 EST
Updates Full Year 2025 Financial Guidance RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025.
